4.7 Review

Chloroquine against malaria, cancers and viral diseases

期刊

DRUG DISCOVERY TODAY
卷 25, 期 11, 页码 2012-2022

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.09.010

关键词

-

资金

  1. National Natural Science Foundation of China [U1903126, 81773888, 81872901]
  2. Guangdong Basic and Applied Basic Research Foundation [2020A1515010005, 2020A1515010605]

向作者/读者索取更多资源

Quinoline (QN) derivatives are often used for the prophylaxis and treatment of malaria. Chloroquine (CQ), a protonated, weakly basic drug, exerts its antimalarial effect mainly by increasing pH and accumulating in the food vacuole of the parasites. Repurposing CQ is an emerging strategy for new indications. Given the inhibition of autophagy and its immunomodulatory action, CQ shows positive efficacy against cancer and viral diseases, including Coronavirus 2019 (COVID-19). Here, we review the underlying mechanisms behind the antimalarial, anticancer and antiviral effects of CQ. We also discuss the clinical evidence for the use of CQ and hydroxychloroquine (HCQ) against COVID-19.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据